...U.S. FDA Approval of First and Only Complete, Single-Pill...
Hepatotoxicity:Hepatic adverse events were reported. Patients with underlying hepatic disease, including hepatitis B or C, or marked elevations in transaminases before treatment may be at increased risk for worsening ...